Aequus Pharmaceuticals Inc (AQS)

Currency in CAD
0.005
0.000(0.00%)
Closed·
Trading near 52-week Low
Fair Value
Day's Range
0.0050.005
52 wk Range
0.0050.020
Key Statistics
Bid/Ask
0.005 / 0.005
Prev. Close
0.005
Open
0.005
Day's Range
0.005-0.005
52 wk Range
0.005-0.02
Volume
-
Average Volume (3m)
600K
1-Year Change
-85.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AQS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Aequus Pharmaceuticals Inc Company Profile

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Compare AQS to Peers and Sector

Metrics to compare
AQS
Peers
Sector
Relationship
P/E Ratio
0.0x−0.4x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.6x2.6x
Price / LTM Sales
0.0x0.7x3.2x
Upside (Analyst Target)
0.0%78.7%42.0%
Fair Value Upside
Unlock15.9%6.6%Unlock

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AQS Income Statement

FAQ

What Stock Exchange Does Aequus Pharmaceuticals Inc Trade On?

Aequus Pharmaceuticals Inc is listed and trades on the CBOE Canada Exchange stock exchange.

What Is the Stock Symbol for Aequus Pharmaceuticals Inc?

The stock symbol for Aequus Pharmaceuticals Inc is "AQS."

What Is the Aequus Pharmaceuticals Inc Market Cap?

As of today, Aequus Pharmaceuticals Inc market cap is 663.17K.

What Is Aequus Pharmaceuticals Inc's Earnings Per Share (TTM)?

The Aequus Pharmaceuticals Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is AQS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aequus Pharmaceuticals Inc Stock Split?

Aequus Pharmaceuticals Inc has split 0 times.

What is the current trading status of Aequus Pharmaceuticals Inc (AQS)?

As of 30 Jul 2025, Aequus Pharmaceuticals Inc (AQS) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 0.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.